Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Various studies revealed that numerous long noncoding RNAs (lncRNAs) have been found dysregulated in
HCC
and played important role in hepatocarcinogenesis, although the underlying mechanism still remains unclear. Herein, we reported AF119895, a new lncRNA which was identified from microarray and amplified in
HCC
. Functionally, AF119895 promoted migration and invasion of
HCC
cells both in vitro and in vivo. Furthermore, we identified that
NXF3
was a downstream target of AF119895.
NXF3
depletion could decrease
HCC
cells migration and invasion. In addition, AF119895 could act as an endogenous sponge by binding to miR-6508-3p and reduce miR-6508-3p expression. And miR-6508-3p could regulate
NXF3
by interacting with its 3'UTR. These observations collectively demonstrate that AF119895 modulates the repression of
NXF3
by binding to miR-6508-3p. Our results outline a novel signaling pathway mediated by AF119895 and suggest its candidacy as a new prognostic biomarker and therapeutic target of
HCC
.
...
PMID:AF119895 regulates NXF3 expression to promote migration and invasion of hepatocellular carcinoma through an interaction with miR-6508-3p. 2927 23